Classification
Product TypeIngredient
Product FormPowder (bulk ingredient)
Industry PositionNutraceutical and Pharmaceutical Mineral Ingredient
Market
Magnesium citrate in India is used primarily as a magnesium source in health supplements/nutraceuticals and as a pharmaceutical-grade material in certain oral products, with demand tied to India’s domestic supplement and pharma manufacturing base. Market access is highly sensitive to regulatory classification: food-positioned products must align with FSSAI’s Health Supplements/Nutraceuticals framework and labeling rules, while drug-positioned presentations follow drug-regulatory pathways. Imported consignments are cleared through FSSAI’s Food Import Clearance System (FICS), integrated with Customs ICEGATE under the single-window process, and may be subject to risk-based sampling and testing. A key compliance pinch point is that FSSAI’s enumerated list of magnesium chemical sources under the 2016 framework does not explicitly name magnesium citrate, which can trigger queries on ingredient permissibility and product approval/route selection.
Market RoleDomestic consumption and formulation market with both domestic manufacture and imports (net trade position not readily separable due to category-level customs classifications).
Domestic RoleB2B input for India’s nutraceutical/health-supplement and pharmaceutical manufacturing sectors; also sold as finished OTC supplement products via retail and e-commerce when formulated/packed locally.
Specification
Physical Attributes- Magnesium citrate is a magnesium salt of citric acid; commonly referenced as trimagnesium dicitrate.
- Supplied as a dry solid/powder ingredient for blending and dosage-form manufacturing.
Compositional Metrics- Typical buyer specifications focus on identity, assay (magnesium and citrate-related), and limits for metal contaminants aligned to applicable Indian contaminant limits and/or relevant pharmacopeial expectations (where applicable).
- For food-positioned products, composition/claims and labeling must align with FSSAI’s health supplements/nutraceuticals framework and RDA-related rules as applicable.
Grades- Pharmacopeial grade (e.g., USP/EP or BP, per supplier documentation)
- Food/nutraceutical ingredient grade (subject to FSSAI category and ingredient permissibility)
Packaging- Common bulk trade packs include multi-kg bags or drums (e.g., 25 kg formats are commonly marketed by suppliers).
Supply Chain
Value Chain- Upstream manufacture (domestic or imported) → incoming QA/CoA verification → risk-based testing (where required) → blending/formulation (nutraceutical/pharma plants) → packaging and labeling → distribution via B2B ingredient channels and finished-product channels.
Temperature- Typically handled as a dry ingredient at ambient temperatures; moisture control is important to maintain flowability and prevent caking.
Atmosphere Control- Keep sealed and protected from humidity during storage and transport.
Shelf Life- Stability is generally storage-condition driven (especially humidity exposure) rather than seasonal supply constraints.
Freight IntensityMedium
Transport ModeMultimodal
Risks
Regulatory Compliance HighRegulatory permissibility ambiguity can block or delay trade: under FSSAI’s 2016 health supplements/nutraceuticals framework, magnesium chemical sources are enumerated and magnesium citrate is not explicitly listed among the named magnesium sources, which can trigger importer queries, detention, or a requirement to pursue an alternate regulatory route (e.g., permitted-source interpretation, product approval for non-specified foods/ingredients, or reformulation).Confirm intended positioning (food vs drug) early; map the ingredient to FSSAI schedules and, if needed, pursue the appropriate approval route (e.g., non-specified food/ingredient product approval) or use a clearly listed magnesium source for food-positioned products; align dossiers and labels to the chosen route before shipment.
Documentation Gap MediumImport delays or rejection can occur if the mandatory document set (e.g., Bill of Entry, CoO, label, ingredient list, end-use declaration) is incomplete, inconsistent, or not aligned to the declared food category and applicable regulation references during FICS processing.Run a pre-shipment document reconciliation checklist aligned to FSSAI’s import manual and ensure label/ingredient disclosures match the declared category and composition.
Food Safety MediumNon-conformance risk exists for mineral ingredients if metal contaminants or other parameters exceed applicable limits, particularly when the product is positioned as a food/nutraceutical ingredient subject to Indian contaminant limits and risk-based testing at import.Qualify suppliers with robust QA systems; require batch CoA and (where needed) third-party test reports against relevant Indian contaminant requirements and buyer specs before dispatch.
Logistics MediumFreight and port/clearance variability can affect delivery timelines for bulk chemical ingredients, especially when shipments are selected for sampling/testing or when clarifications are raised during import processing.Plan lead times for potential testing holds; ship with complete, consistent documentation and maintain buffer inventory for critical SKUs.
Standards- EU-GMP (pharmaceutical manufacturing quality systems; supplier-claimed for some India-based manufacturers)
- DMF-backed documentation expectations (e.g., supplier-claimed USDMF support for pharma buyers)
- HACCP/ISO-type food safety management systems (commonly referenced in nutraceutical ingredient supply chains)
FAQ
Which Indian regulations most directly govern magnesium citrate when used in supplements?If the product is positioned as a health supplement or nutraceutical, it falls under FSSAI’s Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, Functional Food and Novel Food) Regulations, 2016, along with the Food Safety and Standards (Labelling and Display) Regulations, 2020 for labeling. If it is positioned as a drug (e.g., certain cathartic presentations), it generally follows drug-regulatory pathways rather than the FSSAI food framework.
What are the core documents typically required to clear an imported magnesium citrate consignment as a food ingredient in India?FSSAI’s import guidance lists a baseline document set that includes the Bill of Entry, Country of Origin Certificate, Bill of Lading, FSSAI import license, invoice, packing list, ingredient list, product label, and an end-use declaration. The consignment is processed through Customs ICEGATE and FSSAI’s Food Import Clearance System (FICS), where documents are scrutinized and the shipment may be selected for inspection and testing.
Why can magnesium citrate shipments face regulatory questions under the FSSAI nutraceutical framework?FSSAI’s 2016 framework includes an explicit list of chemical sources for minerals, including several named magnesium sources. Magnesium citrate is not explicitly listed among those named magnesium sources, so importers may need to confirm acceptability via the appropriate regulatory route and ensure the product’s composition and labeling align with the declared category before shipment.